An exhilarating conversation with Azeem Azhar on medical A.I., science of aging, genome editing and the GLP-1 drugs
Ground Truths
Evolution of long-acting drugs and changing perceptions in diabetes treatment
In the past, short-acting drugs required multiple injections per day, leading to a push for long-acting drugs. Increasing the drug dosage resulted in unprecedented body weight loss. The first GLP drug in 2005 targeted type 2 diabetes, but diabetes may not have been as prevalent or well-handled as it is today.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
